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Pneumocystis carinii, an organism originally thought to be a protozoan but reclassified as a fungus (1) , causes disease only in the immunocompromised host (2, 3) . In developed nations, P. carinji pneumonia (PCP) is the most common lethal infection of patients with acquired immunodeficiency syndrome (AIDS). Although PCP responds to treatment with trimethoprim-sulfamethoxazole or pentamidine, these drugs frequently cause allergic and toxic side effects when used in AIDS patients. There is, therefore, a need for other effective therapies for the treatment of PCP.
The development of therapeutic agents for PCP has been hampered by the lack of an adequate in vitro culture system of P. carinii. The only model system available for study of PCP is the steroid-induced immunosuppressed rat (4) . In the absence of continuous in vitro cultures, there is currently no source of P. carinii that can provide sufficient material for biochemical studies. In fact, no protein from this organism has been purified. However, DNA libraries have been prepared from rat P. carinii (1) allowing the isolation and heterologous expression of genes encoding proteins that are potential targets for drug development.
We have an ongoing interest in studies of the structure, function, and inhibition of thymidylate synthase (TS). This enzyme catalyzes the reductive methylation of dUMP to dTMP with the concomitant conversion of 5,10-methylenetetrahydrofolate (CH2H4folate) to 7,8-dihydrofolic acid. Since TS is the sole de novo source for dTMP synthesis, it is an attractive target for the development of chemotherapeutic agents. Furthermore, the demonstrated effectiveness of antifolate therapy in the treatment ofP. carinii infections shows that thymine depletion is cytotoxic to these organisms. Based on the large body of information available for TS, inhibitors may be developed that may specifically affect P. carinii. In the present work, we describe the isolation and expression of the TS gene from P. carinii. ¶ MATERIALS AND METHODS Reagents. The following oligonucleotides were synthesized in the Biomolecular Resource Center at the University of California, San Francisco, CA: ONi, 5'-GGAATTCCRTN-TAYGGNTTYCARTGG-3'; ON2, 5 '-GGGATCCCGCNA-TRTTRAANGGNAC-3'; ON4, 5'-GGAGCAGAATATAT-TGATTGC-3'; ON5, 5'-GCAATCAATATATTCTGCTCC-3'; ON6, 5'-GGCATTACCTCCGTGCCATATG-3'; ON7, 5 '-CATATGGCACGGAGGTAATGCC-3'; ON8, 5'-GGGCG-GTCTTCCCCATGG-3'; ON9, 5'-AGCTTGAATTCAGGA-GGTAATTAACCATGGTAAACGCAGAAGAACAACAA-TATCTCAACTTAGTACAATATATTATTAAT-3'; ON10, 5'-CATGATTAATAATATATTGTACTAAGTTGAGATA-TTGTTGTTCTTCTGCGTTTACCATGGTTAATTA-CCTCCTGAATTCA-3'; ON11, 5'-CATGGAATCCTGCAG-ATTTAGAAAAA-3' (where R is a purine, N is any nucleotide, and Y is a pyrimidine). AZAP (6) .
Probe Preparation and Hybridization Conditions. Probe fragments were purified by low-melting-point agarose gel electrophoresis and the GeneClean method. The fragments were labeled with [a-32P]dCTP using the random-priming method. Hybridizations were performed in 50%o (vol/vol) formamide/Sx SSC/10 mM NaH2PO4/0.05% Na4P2O7/5X Denhardt's solution/0.1% SDS at 420C by addition of probe at 106 cpm/ml (lx SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7.0; lx Denhardt's = 0.02% polyvinylpyrrolidone/0.02% Ficoll/0.02% bovine serum albumin). The filters were washed in 0.1x SSC/0.1% SDS/0.05% Na4P207 at 42-50°C and subjected to autoradiography using Kodak XAR-5 x-ray film.
Preparation of cDNA Library. The cDNA library was prepared in AZAP as described (7, 8) .
Screening of Complementary and Genomic DNA Libraries. Approximately, 120,000 phage from each of the genomic DNA and cDNA libraries in AZAP were plated to BB4 cells on NZCYM agar (6) and transferred to nitrocellulose filters. Hybridization and wash conditions were as described above. All isolates were plaque-purified and plasmids were rescued from AZAP as described (9) . Plasmid DNA from five genomic clones and one cDNA clone was mapped with EcoRI, BamHI, HindIII, Pst I, and Nco I, transferred to nitrocellulose, and probed with the cloned PCR product. EcoRI, EcoRI-Pst I, or BamHI-HindIII fragments from genomic clones pUETS-2 and pUETS-6 and cDNA clone pUETS-1 were subcloned into M13mpl8 and -mpl9 for sequence analysis with the Sequenase system using the universal primer as well as four oligonucleotide primers (ON4-7) based on the PCR product sequence. One additional primer, ON8, was required to obtain the sequence of the 5' flanking region. With the exception of the 5' flanking region, all sequences shown in Fig. 3 were determined on both strands for the cDNA and both genomic DNA clones.
Expression of P. carinfi TS in Escherichia coli. To assess expression of functional TS by complementation, plasmid constructs were introduced into E. coli K12 X2913 (Athy-A572) (R. Thompson, University of Glasgow, U.K.) and plated on minimal agar lacking thymidine. Aliquots (2 ml) of minimal medium lacking thymidine were inoculated with single colonies, and cultures were grown to stationary phase. These served as inocula for 20-ml LB cultures containing ampicillin (50 ,ug/ml) and 1 mM isopropyl (3-D-thiogalactopyranoside. Cells were harvested by centrifugation 12 hr later. Pellets were suspended in 2 ml of 100 mM Tris-HCl,pH 7.4/1 mM EDTA/10 mM 2-mercaptoethanol at 4°C, and cells were disrupted by sonication. Cell debris was removed by centrifugation at 10,000 x g for 15 min at 4°C. Protein concentrations were determined by using the method of Bradford (10) . Total cell lysates and soluble extracts from complementing (Thy') transformants were analyzed by SDS/PAGE and TS activity was monitored spectrophotometrically using conditions described (11 A single 403-base-pair (bp) product was amplified from genomic P. carinji DNA (Fig. 1, lane 3) . Amplification of genomic S. cerevisiae DNA (Fig. 1, lane 2) using the same primers yielded a major product of 311 bp corresponding with the predicted fragment size for TS from this source (15) . No amplification products were obtained for a negative control plasmid (Fig. 1, lane 4) or normal rat lung DNA (data not shown). The size of the P. carinii PCR product was 100 bp larger than that expected from known TS sequences, which was later shown to be due to the presence of two intervening (Fig. 2) .
The deletion of 4 bp in this region of the cDNA. To clarify the sequence of the mature cDNA, the mixed PCR primers were used to amplify oligo(dT)-primed P. carinii cDNA. A 311-bp product corresponding to the predicted size of mature mRNA was obtained. Sequence analysis of the cloned PCR product clearly showed the presence of GCAG at nucleotide positions 532-535, which confirmed the deletion in pUETS-1, precisely at the exon-intron junction. This sequence was also in agreement with that ofboth genomic clones, which shows the GAT codon for Asp-164 split after the first base by intervening sequence (IVS) II. The putative deletion in pUETS-1 was corrected by site-directed mutagenesis (see below). The cDNA sequence contained an open reading frame of 1086 bp (Fig. 3) . No other in-frame ATGs in the nucleotide sequence were present 5' to the predicted initiation codon. The first in-frame ATG codon downstream from the predicted initiation codon occurs well into the highly conserved coding sequence (amino acid 168). Also, the predicted initiation codon is preceded by an adenosine at position -3 and followed by a guanosine at position +4, an environment favorable for translation initiation (16) . The cDNA clone also contained 143 bp of 5' flanking sequence and 114 bp of 3' flanking sequence preceding a short poly(A)tail (Fig. 3) .
Translation of the open reading frame yields a polypeptide of 297 amino acids with a molecular weight of 34, 269 . The deduced amino acid sequence shows conservation of all the amino acid residues that are invariant in known TSs. Overall amino acid identities range from 40% with T4 phage TS (17) , to 60% with human TS (18) , to 65% with S. cerevisiae TS (15) . The coding sequence has an A+T content of 64% and 78% A or T in the third position of codons.
IVSs in the TS Gene. The nucleotide sequence of genomic DNA clones pUETS-2 and pUETS-6 was identical over the coding and flanking regions presented in Fig. 3 . Four IVSs at nucleotides 203-247 (IVS I, 45 bp), 536-580 (IVS II, 45 bp), 621-675 (IVS III, 55 bp), and 855-903 (IVS IV, 49 bp) were identified by comparison to the cDNA clone pUETS-1. From the available data, the hexanucleotide G Y A W W M, where W is A or T and M is A or C, serves as a 5' splice junction consensus sequence for P. carinii IVSs. With exception of the first three nucleotides, the 5' splicejunction sequences do not correspond to, and are less well conserved than, those identified in other fungi (19) . No conserved branch site sequences similar to the TACTAAC consensus sequence of S. cerevisiae IVSs or the more variable C T R A Y consensus sequence of Schizosaccharomyces pombe IVSs are identifiable in these IVSs (20, 21) . The conserved TAG sequence characteristic of most 3' splice junctions, however, is present in all four P. carinii TS IVSs.
Expression of P. carini TS. Three plasmids were constructed for the expression of P. carindi TS in E. coli. The EcoRI fragment of pUETS-1 was ligated into pUC9 to yield pUETS-1.1. Two complementary oligonucleotides (ON9 and ON10) were prepared as an adapter that contains 5' HindIII and EcoRI restriction sites followed by a Shine-Dalgarno sequence, stop codons in all three reading frames, the start codon, the nucleotides encoding the first 18 amino acids ofP. carindi TS and a 3' Nco I overhang. Two silent sequence modifications were made in the coding sequence: (t) An Nco I site was introduced at the start codon to allow transfer ofthe gene into other expression vectors, and (ii) the first base of the natural Nco I site at position +54 was changed from cytidine to thymidine to remove this restriction site. Neither change alters the amino acid sequence. These adapters were phosphorylated, annealed, and ligated into HindIII and Nco I sites of pUETS-1.1 from which the HindIII-Nco I fragment containing the 5' flanking and coding region had been removed to give pUETS-1.2. The HindIII-BamHI fragment of pUETS-1.2 was subcloned into M13mpl8. The putative deletion at position 535 was corrected by oligonucleotidedirected mutagenesis using ON9 and the entire coding sequence was confirmed by nucleotide sequence analysis. The EcoRI fragment was then isolated from this subclone and ligated into pUC9 (pUETS-1.6) and pUC18 (pUETS-1.7) for expression of the P. carinii TS under control of the lac promoter. It was also inserted into M13mpl9 (pUETS-1.5) to attain desired restriction sites from the vector. An Nco I-HindIII fragment was isolated from pUETS-1.5 and subcloned into pKK233-2 to yield pUETS-1.8 for expression under the control of the tac promoter (22) .
Plasmids pUETS-1.6, -1.7, and -1.8 complemented Thy-E. coli X2913 on minimal medium that lacked thymidine. (Fig. 4) . The discrepancy between the predicted subunit molecular weight of P. carinii TS and the apparent molecular weight by SDS/PAGE is also seen in S. cerevisiae TS (25) . DISCUSSION Our initial attempts to isolate the TS gene from P. carinii by screening the genomic library using a variety of heterologous hybridization probes failed. As probes, we tried the TS genes from Leishmania major (26, 27) , Plasmodium falciparum (28) , and Herpesvirus saimiri (29) , as well as two degenerate oligonucleotides based on conserved sequences of TS; the hybridization conditions were also varied to such low stringency that numerous false positives were uncovered. To obtain a suitable hybridization probe, we decided to use 256-fold degenerate oligonucleotides as PCR primers to amplify a fragment of the TS gene from P. carinii genomic DNA. The strategy used was to choose two highly conserved regions of eukaryotic TSs and to prepare a mixture of synthetic oligonucleotide primers that contains all possible sequences of these regions. By using this approach, we were able to amplify a 403-bp sequence of P. carinii TS. The amino acid sequence deduced from this sequence showed signifi- carinji (1, 19 (Fig. 4) .
P. carinji has long been classified as a protozoan but small subunit rRNA gene sequence analysis has indicated that it is a fungus (1) . In protozoa, TS and dihydrofolate reductase exist as a bifunctional protein on the same polypeptide chain, whereas in other organisms, perhaps with exception of plants (33) , the enzymes are clearly distinct and monofunctional. Limited nucleotide sequence analysis of the flanking sequences ofP. carinii TS did not reveal proximal open reading frames that could encode dihydrofolate reductase. Further, TAFE demonstrated that TS and dihydrofolate reductase reside on different P. carinji chromosomes (35) . Thus, our results support the contention that P. carinii is not a protozoan.
P. carinii TS contains all of the conserved amino acid residues contributing to important structural elements identified in the x-ray structure of L. casei TS and is, therefore, likely to have a similar core three-dimensional structure (32) . The amino acid sequence shows both of the invariant eukaryote-specific insertions; a 12-amino acid loop at position 90 (between a-D and E helices) and the 8-amino acid loop after residue 157 (between a-G and H helices) of the L. casei TS. The single-amino acid insertion after residue 34 has thus far been observed only in the other fungal TSs characterized (serine in P. carinii, proline in S. cerevisiae and Candida albicans) (15, 34) . This insertion is found in the first 3-strand of TS, which forms an important interface for subunit contact. Another single-amino acid insertion after residue 43 is also present in fungal and kinetoplastid TSs. The insertion is located on a loop that would connect the first /-strand i to the a-helix B. A 6-amino acid insertion after residue 210 forms part of an exposed surface loop between -3-strands iii and iv. Insertions at this position of TS have thus far only beewseen as a 9-amino acid insertion in S. cerevisiae TS, a 17-amino acid insertion in C. albicans TS, and a 2-amino acid insertion in kinetoplastid TSs. Additional pertinent differences between human and P. carinji TS in nonconserved residues contributing to the active site may provide the basis for molecular design of selective inhibitors of P. carinii TS.
In summary, we have isolated, characterized, and expressed the P. carinji TS gene in E. coli. Abundant catalytically active P. carinii TS is now available to pursue studies on the structure, function, and inhibition of this enzyme.
